Justices Won't Review Do-Overs Of Whistleblower FCA Cases
By Adam Lidgett · January 11, 2021, 4:54 PM EST
The U.S. Supreme Court on Monday shot down Bristol-Myers Squibb and Sanofi's challenge to a decision that allowed New Mexico to proceed with allegations of unlawful drug marketing even though a...
To view the full article, register now.